DaVita Inc
NYSE:DVA

Watchlist Manager
DaVita Inc Logo
DaVita Inc
NYSE:DVA
Watchlist
Price: 165.51 USD 0.83% Market Closed
Market Cap: 13.6B USD
Have any thoughts about
DaVita Inc?
Write Note

Net Margin
DaVita Inc

6.5%
Current
6%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
6.5%
=
Net Income
827.7m
/
Revenue
12.7B

Net Margin Across Competitors

Country US
Market Cap 13.7B USD
Net Margin
7%
Country US
Market Cap 91.8B USD
Net Margin
1%
Country US
Market Cap 87.7B EUR
Net Margin
1%
Country US
Market Cap 73B USD
Net Margin
1%
Country DE
Market Cap 24.9B EUR
Net Margin
3%
Country US
Market Cap 20.1B USD
Net Margin
3%
Country DE
Market Cap 18.8B EUR
Net Margin
-2%
Country US
Market Cap 18.3B USD
Net Margin
9%
Country DE
Market Cap 12.4B EUR
Net Margin
3%
Country AU
Market Cap 13.4B AUD
Net Margin
6%
Country US
Market Cap 8.6B USD
Net Margin
13%
No Stocks Found

DaVita Inc
Glance View

Market Cap
13.7B USD
Industry
Health Care

DaVita Inc. has emerged as a leading healthcare provider specializing in kidney care, operating over 2,800 outpatient dialysis centers across the United States and 10 additional countries. Founded in 1994, the company has made significant strides in enhancing the quality of life for individuals battling chronic kidney disease. With a mission deeply rooted in patient care, DaVita focuses on delivering comprehensive treatment and support, ensuring that patients receive not only dialysis services but also vital education and resources for managing their condition. This commitment to patient-centric care has positioned DaVita as a notable player in the burgeoning healthcare sector, making it an attractive investment opportunity for those interested in the resilience and growth potential within the industry. From an investor's perspective, DaVita represents a blend of stability and growth potential, driven by an aging population that increasingly requires kidney care services. The company benefits from a favorable reimbursement landscape and has implemented operational efficiencies that enhance profitability. In recent years, DaVita has also ventured into value-based care initiatives, which align incentives towards improved patient outcomes rather than volume. This strategic pivot not only secures a sustainable revenue model but also highlights the company’s adaptability in a rapidly changing healthcare environment. As such, DaVita stands out in the investment community, offering a chance to capitalize on a vital sector poised for expansion, all while contributing to the well-being of countless patients.

DVA Intrinsic Value
226.71 USD
Undervaluation 27%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
6.5%
=
Net Income
827.7m
/
Revenue
12.7B
What is the Net Margin of DaVita Inc?

Based on DaVita Inc's most recent financial statements, the company has Net Margin of 6.5%.